Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134658) titled 'The impact of esketamine on postoperative pain, anxiety, and depression in patients undergoing tumor surgery' on Oct. 19.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Huzhou Central Hospital
Condition:
tumor
Intervention:
Control group (C group):Sufentanil 100 µg + granisetron 6 mg diluted with 0.9% sodium chloride injection to a total volume of 100 mL for PCIA
initial dose 0.01 µg/kg, background dose 0.03 µg/kg/h, and single bolus dose 0.05 µg/kg per administration.
High-dose esketamine group (D1 group):Sufentanil 100 µg + esketamine 50 mg + granisetron ...